<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

HLA Gene Editing to Treat Refractory Rheumatoid Arthritis

Brian M. Freed, PhD, FACHI

by Department of Medicine | November 15, 2022

Watch the Department of Medicine's Nov. 15, 2022 Research & Innovation Conference: "HLA Gene Editing to Treat Refractory Rheumatoid Arthritis" with Brian Freed, PhD, FACHI, Executive Director, ClinImmune Cell & Gene Therapy; professor of medicine and immunology, Division of Allergy, Asthma and Clinical Immunology, Department of Medicine, University of Colorado School of Medicine.

 

Topics: Research